Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Subscribe To Our Newsletter & Stay Updated